Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Period blood may offer a needle-free HPV test — a trial puts it to the test

NCT ID NCT07733557

Diagnosis Sponsor: Samantha Batman Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time

Summary

This study is testing whether human papillomavirus (HPV) can be accurately detected from menstrual blood collected at home. Participants who had a routine HPV test within the past 90 days will use a special kit to collect a menstrual blood sample. The results will be compared with their earlier clinical test to see if the two methods agree. If successful, menstrual blood sampling could become a noninvasive, convenient option for HPV screening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Endometrics Menstrual Blood Collection Kit (a self-collection device for menstrual blood sampling)
What this could lead to
If menstrual blood testing proves accurate, it could offer a simpler, less invasive way to screen for HPV without a clinic visit.
What could go wrong
This is a small, early-stage study with only 50 participants. The menstrual blood test may not match the accuracy of standard cervical HPV testing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 49 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are 21 to 49 years old. * Are female, have not yet gone through menopause, and expect to have a menstrual period during the study. * Have a cervix (have not had a hysterectomy that removed the cervix). Had a routine high-risk HPV (human papillomavirus) test within the past 90 days and received a valid result (positive or negative). * Receive medical care at the participating clinic and have been identified by the study team as a possible candidate for the study. * Can read, understand, and communicate in English. * Are willing and able to follow study procedures, including using a menstrual blood collection kit and returning the sample for testing. * Are willing to provide informed consent before any study procedures are performed. * May be of any race or ethnicity. Exclusion Criteria: * Had an HPV test in the past 90 days, but the result was unclear, invalid, or could not be interpreted. * Are currently pregnant. * Have had a hysterectomy that removed the cervix. * Are not currently having menstrual periods or are unable to provide a menstrual blood sample during the study period. * Have a medical, mental health, cognitive, social, or other condition that, in the opinion of the study doctor, could make it difficult to safely participate or complete the study procedures. * Are unable to understand the study requirements, use the collection kit, or return the sample for testing. * Do not wish to participate, withdraw consent, or are unwilling to complete the required study procedures. * Are taking part in another research study or have another circumstance that, in the opinion of the study team, could affect study results or participant safety. * Are currently incarcerated.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Human papillomavirus (HPV) infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

human papilloma virus infection Infections

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Human papillomavirus (HPV) infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Virginia

    Charlottesville, Virginia, 22903, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.